Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 19 studies | 40% ± 12% | |
lung | 18 studies | 45% ± 19% | |
intestine | 12 studies | 36% ± 19% | |
kidney | 8 studies | 41% ± 13% | |
brain | 6 studies | 30% ± 7% | |
pancreas | 5 studies | 52% ± 25% | |
placenta | 5 studies | 46% ± 19% | |
bone marrow | 5 studies | 31% ± 10% | |
uterus | 5 studies | 46% ± 24% | |
liver | 5 studies | 39% ± 21% | |
lymph node | 5 studies | 46% ± 13% | |
prostate | 4 studies | 31% ± 9% | |
breast | 4 studies | 44% ± 9% | |
heart | 3 studies | 26% ± 8% | |
adrenal gland | 3 studies | 36% ± 9% | |
esophagus | 3 studies | 51% ± 30% | |
skin | 3 studies | 38% ± 13% | |
thymus | 3 studies | 57% ± 30% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 10065.33 | 21 / 21 | 100% | 129.87 | 504 / 504 |
esophagus | 100% | 9709.14 | 1445 / 1445 | 100% | 135.21 | 183 / 183 |
intestine | 100% | 9104.42 | 966 / 966 | 100% | 99.99 | 527 / 527 |
ovary | 100% | 9170.31 | 180 / 180 | 100% | 177.89 | 430 / 430 |
prostate | 100% | 9410.65 | 245 / 245 | 100% | 117.86 | 502 / 502 |
stomach | 100% | 6683.48 | 359 / 359 | 100% | 115.86 | 286 / 286 |
thymus | 100% | 14664.55 | 653 / 653 | 100% | 128.92 | 605 / 605 |
uterus | 100% | 11076.43 | 170 / 170 | 100% | 137.24 | 459 / 459 |
skin | 100% | 13771.00 | 1808 / 1809 | 100% | 180.96 | 472 / 472 |
lung | 100% | 17176.02 | 578 / 578 | 100% | 122.61 | 1154 / 1155 |
kidney | 100% | 10510.36 | 89 / 89 | 100% | 101.57 | 899 / 901 |
adrenal gland | 100% | 12250.78 | 258 / 258 | 100% | 83.27 | 229 / 230 |
breast | 100% | 14311.17 | 459 / 459 | 100% | 112.72 | 1113 / 1118 |
brain | 98% | 10904.19 | 2600 / 2642 | 100% | 90.54 | 705 / 705 |
pancreas | 98% | 4488.03 | 321 / 328 | 100% | 111.64 | 178 / 178 |
liver | 88% | 3542.29 | 200 / 226 | 100% | 62.14 | 405 / 406 |
adipose | 100% | 18231.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 75.57 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 148.77 | 29 / 29 |
spleen | 100% | 13123.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 121.43 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 58.42 | 1 / 1 |
blood vessel | 100% | 9387.91 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 6958.89 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 14078.06 | 916 / 929 | 0% | 0 | 0 / 0 |
muscle | 97% | 4459.96 | 776 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0022417 | Biological process | protein maturation by protein folding |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0060347 | Biological process | heart trabecula formation |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0032880 | Biological process | regulation of protein localization |
GO_0032926 | Biological process | negative regulation of activin receptor signaling pathway |
GO_0050776 | Biological process | regulation of immune response |
GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
GO_0006457 | Biological process | protein folding |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0097435 | Biological process | supramolecular fiber organization |
GO_0006458 | Biological process | 'de novo' protein folding |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042026 | Biological process | protein refolding |
GO_0014809 | Biological process | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion |
GO_0060314 | Biological process | regulation of ryanodine-sensitive calcium-release channel activity |
GO_0042110 | Biological process | T cell activation |
GO_0003007 | Biological process | heart morphogenesis |
GO_1902991 | Biological process | regulation of amyloid precursor protein catabolic process |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0000413 | Biological process | protein peptidyl-prolyl isomerization |
GO_0016020 | Cellular component | membrane |
GO_0030018 | Cellular component | Z disc |
GO_0014802 | Cellular component | terminal cisterna |
GO_1990425 | Cellular component | ryanodine receptor complex |
GO_0098562 | Cellular component | cytoplasmic side of membrane |
GO_0005829 | Cellular component | cytosol |
GO_0016529 | Cellular component | sarcoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0033017 | Cellular component | sarcoplasmic reticulum membrane |
GO_0005527 | Molecular function | macrolide binding |
GO_0070697 | Molecular function | activin receptor binding |
GO_0003755 | Molecular function | peptidyl-prolyl cis-trans isomerase activity |
GO_0030547 | Molecular function | signaling receptor inhibitor activity |
GO_0034713 | Molecular function | type I transforming growth factor beta receptor binding |
GO_0016247 | Molecular function | channel regulator activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0070411 | Molecular function | I-SMAD binding |
GO_0005528 | Molecular function | FK506 binding |
GO_0005160 | Molecular function | transforming growth factor beta receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FKBP1A |
Protein name | Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP prolyl isomerase 1A FK506 binding protein12 (FKBP prolyl isomerase 1A) peptidylprolyl isomerase (EC 5.2.1.8) |
Synonyms | FKBP12-Exip3 FKBP12 FKBP12-Exip2 FKBP12-Exin FKBP1 |
Description | FUNCTION: Keeps in an inactive conformation TGFBR1, the TGF-beta type I serine/threonine kinase receptor, preventing TGF-beta receptor activation in absence of ligand. Recruits SMAD7 to ACVR1B which prevents the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. May modulate the RYR1 calcium channel activity. PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. . |
Accessions | Q5W0X3 ENST00000439640.5 ENST00000381724 ENST00000677533.1 ENST00000614856.2 ENST00000678136.1 Q0VDC5 ENST00000618612.5 ENST00000381719.8 Q0VDC6 ENST00000677335.1 F6T7Q3 ENST00000612074.5 A0A7I2V3S6 ENST00000381715.4 A0A087WZM5 Q1JUQ5 ENST00000400137.9 P62942 ENST00000678408.1 ENST00000381724.8 Q1JUQ3 A0A087WTS4 |